Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Sep;59(9):790–793. doi: 10.1136/thx.2003.013599

Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma

L Freitag 1, A Ernst 1, M Thomas 1, R Prenzel 1, B Wahlers 1, H Macha 1
PMCID: PMC1747135  PMID: 15333857

Abstract

Background: Bulky endobronchial tumours in patients with lung cancer are difficult to treat. Brachytherapy and photodynamic therapy (PDT) are variably effective, and the combination of these treatments is not often recommended. However, cell culture studies and animal studies indicate a possible synergistic effect of combining PDT with ionising radiation. We assessed the safety and effectiveness of combined brachytherapy and PDT in patients with bulky endobronchial lung cancer.

Methods: Patients with histologically proven non-small cell bronchogenic carcinoma and bulky endobronchial tumours were treated using a combination of PDT (Photofrin, 2 mg/kg) and brachytherapy. Six weeks after PDT, brachytherapy was applied with five fractions of 4 Gy at weekly intervals. Follow up was performed with standard and autofluorescence bronchoscopy and tissue biopsies every 3 months.

Results: Thirty two patients were treated. Tumours were extensive with lengths ranging from 10 to 60 mm along the bronchus and estimated volumes ranging from 40 to 3500 mm3. At a mean follow up of 24 months, 26 patients were free of residual tumour and local recurrence. The remaining patients received a second treatment with PDT, brachytherapy, Nd:YAG laser coagulation, or external beam radiation. Distant metastases (lung, lymph node) developed in two of the six patients. Currently, all 32 patients are well. There is no evidence of residual or local recurrent endobronchial cancer in 28 patients and none had severe complications.

Conclusion: The combination of PDT and brachytherapy for treating patients with lung cancer and extensive endobronchial tumour is safe and, in this study, had excellent therapeutic efficacy.

Full Text

The Full Text of this article is available as a PDF (49.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biel M. A., Kim T., Trump M. J. Effect of radiation therapy and Photofrin on tissue response in a rat model. Lasers Surg Med. 1993;13(6):672–676. doi: 10.1002/lsm.1900130612. [DOI] [PubMed] [Google Scholar]
  2. Cortese D. A., Edell E. S., Kinsey J. H. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 1997 Jul;72(7):595–602. doi: 10.1016/S0025-6196(11)63563-5. [DOI] [PubMed] [Google Scholar]
  3. Cortese D. A., Edell E. S. Role of phototherapy, laser therapy, brachytherapy, and prosthetic stents in the management of lung cancer. Clin Chest Med. 1993 Mar;14(1):149–159. [PubMed] [Google Scholar]
  4. Dobler-Girdziunaite D., Burkard W., Haller U., Larsson B., Walt H. Kombinierte Anwendung der photodynamischen Therapie mit ionisierenden Strahlen bei Mammakarzinomzellen in vitro. Strahlenther Onkol. 1995 Nov;171(11):622–629. [PubMed] [Google Scholar]
  5. Edell E. S., Cortese D. A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest. 1992 Nov;102(5):1319–1322. doi: 10.1378/chest.102.5.1319. [DOI] [PubMed] [Google Scholar]
  6. Freitag L., Korupp A., Itzigehl I., Dankwart F., Tekolf E., Reichle G., Kullmann H. J., Macha H. N. Erfahrungen mit Fluoreszenzdiagnostik und photodynamischer Therapie im multimodalen Therapiekonzept des operierten, rezidivierenden Bronchialkarzinoms. Pneumologie. 1996 Oct;50(10):693–699. [PubMed] [Google Scholar]
  7. Furuse K., Fukuoka M., Kato H., Horai T., Kubota K., Kodama N., Kusunoki Y., Takifuji N., Okunaka T., Konaka C. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol. 1993 Oct;11(10):1852–1857. doi: 10.1200/JCO.1993.11.10.1852. [DOI] [PubMed] [Google Scholar]
  8. He X. Y., Sikes R. A., Thomsen S., Chung L. W., Jacques S. L. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol. 1994 Apr;59(4):468–473. doi: 10.1111/j.1751-1097.1994.tb05066.x. [DOI] [PubMed] [Google Scholar]
  9. Hogg James C., Chu Fanny, Utokaparch Soraya, Woods Ryan, Elliott W. Mark, Buzatu Liliana, Cherniack Ruben M., Rogers Robert M., Sciurba Frank C., Coxson Harvey O. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004 Jun 24;350(26):2645–2653. doi: 10.1056/NEJMoa032158. [DOI] [PubMed] [Google Scholar]
  10. Imamura S., Kusunoki Y., Takifuji N., Kudo S., Matsui K., Masuda N., Takada M., Negoro S., Ryu S., Fukuoka M. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer. 1994 Mar 15;73(6):1608–1614. doi: 10.1002/1097-0142(19940315)73:6<1608::aid-cncr2820730611>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  11. Lam S., Kostashuk E. C., Coy E. P., Laukkanen E., LeRiche J. C., Mueller H. A., Szasz I. J. A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma. Photochem Photobiol. 1987 Nov;46(5):893–897. doi: 10.1111/j.1751-1097.1987.tb04865.x. [DOI] [PubMed] [Google Scholar]
  12. Lam S., Müller N. L., Miller R. R., Kostashuk E. C., Szasz I. J., LeRiche J. C., Lee-Chuy E. Predicting the response of obstructive endobronchial tumors to photodynamic therapy. Cancer. 1986 Nov 15;58(10):2298–2306. doi: 10.1002/1097-0142(19861115)58:10<2298::aid-cncr2820581024>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  13. Macha H. N., Freitag L. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Monaldi Arch Chest Dis. 1996 Aug;51(4):325–328. [PubMed] [Google Scholar]
  14. McCaughan J. S., Jr, Williams T. E. Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg. 1997 Dec;114(6):940–947. doi: 10.1016/S0022-5223(97)70008-4. [DOI] [PubMed] [Google Scholar]
  15. Pérol M., Caliandro R., Pommier P., Malet C., Montbarbon X., Carrie C., Ardiet J. M. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest. 1997 May;111(5):1417–1423. doi: 10.1378/chest.111.5.1417. [DOI] [PubMed] [Google Scholar]
  16. Trédaniel J., Hennequin C., Zalcman G., Walter S., Homasson J. P., Maylin C., Hirsch A. Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest. 1994 Mar;105(3):767–772. doi: 10.1378/chest.105.3.767. [DOI] [PubMed] [Google Scholar]
  17. Vincent R. G., Dougherty T. J., Rao U., Boyle D. G., Potter W. R. Photoradiation therapy in advanced carcinoma of the trachea and bronchus. Chest. 1984 Jan;85(1):29–33. doi: 10.1378/chest.85.1.29. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES